市場調査レポート

商品コード

1442833

アレルギー免疫療法市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Allergy Immunotherapy Market [Treatment: Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)]- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2024年01月03日 | 発行: Transparency Market Research

| ページ情報: 英文 222 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 910,626円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,382,046円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,853,466円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

アレルギー免疫療法市場 - レポートの範囲

世界のアレルギー免疫療法市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とみなし、2017年から2031年までの世界のアレルギー免疫療法市場の収益を提供します。2023年から2031年までの世界のアレルギー免疫療法市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、アレルギー免疫療法市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のアレルギー免疫療法市場の競合情勢を詳しく掘り下げています。世界のアレルギー免疫療法市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、SWOTは、このレポートで紹介されている世界のアレルギー免疫療法市場のプレーヤーの属性です。

市場企業 - 競合マトリックス（企業の階層および規模別）
市場シェア分析：企業別（2021年）
企業プロファイル
- ALK-Abello A/S
- Allergy Therapeutics
- Stallergenes Greer
- HAL Allergy Group
- DBV Technologies
- Merck KGaA
- Aimmune Therapeutics
- Carcassia
- Anergis
- Biomay AG

図表

List of Figures

Figure 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Allergy Immunotherapy Market Value Share, by Treatment, 2022
Figure 03: Global Allergy Immunotherapy Market Value Share, by Distribution Channel, 2022
Figure 04: Global Allergy Immunotherapy Market Value Share, by Region, 2022
Figure 05: Global Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
Figure 06: Global Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
Figure 07: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Silicone, 2017-2031
Figure 08: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Polyolefins, 2017-2031
Figure 9: Global Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
Figure 10: Global Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
Figure 11: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Allergic Rhinitis, 2017-2031
Figure 12: Global Allergy Immunotherapy Market Revenue (US$ Mn), Asthma, 2017-2031
Figure 13: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Food Allergy, 2017-2031
Figure 14: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Venom Allergy, 2017-2031
Figure 15: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Others, 2017-2031
Figure 16: Global Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
Figure 17: Global Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 18: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
Figure 19: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Retail Pharmacies & Drug Stores, 2017-2031
Figure 20: Global Allergy Immunotherapy Market Revenue (US$ Mn), by Online Pharmacies, 2017-2031
Figure 21: Global Allergy Immunotherapy Market Value Share Analysis, by Region, 2022 and 2031
Figure 22: Global Allergy Immunotherapy Market Attractiveness Analysis, by Region, 2023-2031
Figure 23: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 24: North America Allergy Immunotherapy Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Allergy Immunotherapy Market Attractiveness Analysis, by Country, 2023-2031
Figure 26: North America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
Figure 27: North America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
Figure 28: North America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
Figure 29: North America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
Figure 30: North America Allergy Immunotherapy Market Value Share Analysis (US$ Mn), by Distribution Channel, 2017-2031
Figure 31: North America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 32: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 33: Europe Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 34: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 35: Europe Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
Figure 36: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
Figure 37: Europe Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
Figure 38: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
Figure 39: Europe Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
Figure 40: Europe Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 41: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 43: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 44: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
Figure 45: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
Figure 46: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2022 and 2031
Figure 47: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
Figure 48: Asia Pacific Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
Figure 49: Asia Pacific Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 50: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 51: Latin America Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 53: Latin America Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
Figure 54: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
Figure 55: Latin America Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017-2031
Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
Figure 54: Latin America Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
Figure 55: Latin America Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 56: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, 2017-2031
Figure 57: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 59: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Treatment, 2022 and 2031
Figure 60: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Treatment, 2023-2031
Figure 61: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Allergy Type, 2017-2031
Figure 62: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Allergy Type, 2023-2031
Figure 63: Middle East & Africa Allergy Immunotherapy Market Value Share Analysis, by Distribution Channel, 2017-2031
Figure 64: Middle East & Africa Allergy Immunotherapy Market Attractiveness Analysis, by Distribution Channel, 2023-2031

List of Tables

Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 01: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
Table 02: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 04: Global Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 07: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
Table 08: North America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 09: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 11: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 12: Europe Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
Table 13: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 15: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
Table 16: Asia Pacific Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 17: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 19: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
Table 20: Latin America Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 21: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
Table 23: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Allergy Type, 2017-2031
Table 24: Middle East & Africa Allergy Immunotherapy Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Product Code: TMRGL35708

Allergy Immunotherapy Market - Scope of Report

TMR's report on the global allergy immunotherapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global allergy immunotherapy market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global allergy immunotherapy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the allergy immunotherapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global allergy immunotherapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global allergy immunotherapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global allergy immunotherapy market.

The report delves into the competitive landscape of the global allergy immunotherapy market. Key players operating in the global allergy immunotherapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global allergy immunotherapy market profiled in this report.

Key Questions Answered in Global allergy immunotherapy Market Report:

What is the sales/revenue generated by allergy immunotherapy across all regions during the forecast period?
What are the opportunities in the global allergy immunotherapy market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Allergy Immunotherapy Market - Research Objectives and Research Approach

The comprehensive report on the global allergy immunotherapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global allergy immunotherapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global allergy immunotherapy market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy Immunotherapy Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Allergy Immunotherapy Market Analysis and Forecast, 2017-2031
4.5. Porter's Five Force Analysis

5. Key Insights

5.1. COVID-19 Pandemic Impact on Industry

6. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment, 2017-2031
- 6.3.1. Subcutaneous Immunotherapy (SCIT)
- 6.3.2. Sublingual Immunotherapy (SLIT)
6.4. Market Attractiveness Analysis, by Treatment

7. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Allergy Type, 2017-2031
- 7.3.1. Allergic Rhinitis
- 7.3.2. Asthma
- 7.3.3. Food Allergy
- 7.3.4. Venom Allergy
- 7.3.5. Others
7.4. Market Attractiveness Analysis, By Allergy Type

8. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 8.3.1. Hospital Pharmacies
- 8.3.2. Retail Pharmacies & Drug Stores
- 8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, By Distribution Channel

9. Global Allergy Immunotherapy Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Allergy Immunotherapy Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment, 2017-2031
- 10.2.1. Subcutaneous Immunotherapy (SCIT)
- 10.2.2. Sublingual Immunotherapy (SLIT)
10.3. Market Value Forecast, by Allergy Type, 2017-2031
- 10.3.1. Allergic Rhinitis
- 10.3.2. Asthma
- 10.3.3. Food Allergy
- 10.3.4. Venom Allergy
- 10.3.5. Others
10.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.4.1. Hospital Pharmacies
- 10.4.2. Retail Pharmacies & Drug Stores
- 10.4.3. Online Pharmacies
10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
10.6. Market Attractiveness Analysis
- 10.6.1. By Treatment
- 10.6.2. By Allergy Type
- 10.6.3. By Distribution Channel
- 10.6.4. By Country

11. Europe Allergy Immunotherapy Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment, 2017-2031
- 11.2.1. Subcutaneous Immunotherapy (SCIT)
- 11.2.2. Sublingual Immunotherapy (SLIT)
11.3. Market Value Forecast, by Allergy Type, 2017-2031
- 11.3.1. Allergic Rhinitis
- 11.3.2. Asthma
- 11.3.3. Food Allergy
- 11.3.4. Venom Allergy
- 11.3.5. Others
11.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.4.1. Hospital Pharmacies
- 11.4.2. Retail Pharmacies & Drug Stores
- 11.4.3. Online Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Treatment
- 11.6.2. By Allergy Type
- 11.6.3. By Distribution Channel
- 11.6.4. By Country/Sub-region

12. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment, 2017-2031
- 12.2.1. Subcutaneous Immunotherapy (SCIT)
- 12.2.2. Sublingual Immunotherapy (SLIT)
12.3. Market Value Forecast, by Allergy Type, 2017-2031
- 12.3.1. Allergic Rhinitis
- 12.3.2. Asthma
- 12.3.3. Food Allergy
- 12.3.4. Venom Allergy
- 12.3.5. Others
12.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.4.1. Hospital Pharmacies
- 12.4.2. Retail Pharmacies & Drug Stores
- 12.4.3. Online Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. India
- 12.5.3. Japan
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Treatment
- 12.6.2. By Allergy Type
- 12.6.3. By Distribution Channel
- 12.6.4. By Country/Sub-region

13. Latin America Allergy Immunotherapy Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment, 2017-2031
- 13.2.1. Subcutaneous Immunotherapy (SCIT)
- 13.2.2. Sublingual Immunotherapy (SLIT)
13.3. Market Value Forecast, by Allergy Type, 2017-2031
- 13.3.1. Allergic Rhinitis
- 13.3.2. Asthma
- 13.3.3. Food Allergy
- 13.3.4. Venom Allergy
- 13.3.5. Others
13.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.4.1. Hospital Pharmacies
- 13.4.2. Retail Pharmacies & Drug Stores
- 13.4.3. Online Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Treatment
- 13.6.2. By Allergy Type
- 13.6.3. By Distribution Channel
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment, 2017-2031
- 14.2.1. Subcutaneous Immunotherapy (SCIT)
- 14.2.2. Sublingual Immunotherapy (SLIT)
14.3. Market Value Forecast, by Allergy Type, 2017-2031
- 14.3.1. Allergic Rhinitis
- 14.3.2. Asthma
- 14.3.3. Food Allergy
- 14.3.4. Venom Allergy
- 14.3.5. Others
14.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.4.1. Hospital Pharmacies
- 14.4.2. Retail Pharmacies & Drug Stores
- 14.4.3. Online Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Treatment
- 14.6.2. By Allergy Type

15. Competition Landscape

15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
- 15.3.1. ALK-Abello A/S
  - 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.1.2. Treatment Portfolio
  - 15.3.1.3. Financial Overview
  - 15.3.1.4. SWOT Analysis
  - 15.3.1.5. Strategic Overview
- 15.3.2. Allergy Therapeutics
  - 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.2.2. Treatment Portfolio
  - 15.3.2.3. Financial Overview
  - 15.3.2.4. SWOT Analysis
  - 15.3.2.5. Strategic Overview
- 15.3.3. Stallergenes Greer
  - 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.3.2. Treatment Portfolio
  - 15.3.3.3. Financial Overview
  - 15.3.3.4. SWOT Analysis
  - 15.3.3.5. Strategic Overview
- 15.3.4. HAL Allergy Group
  - 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.4.2. Treatment Portfolio
  - 15.3.4.3. Financial Overview
  - 15.3.4.4. SWOT Analysis
  - 15.3.4.5. Strategic Overview
- 15.3.5. DBV Technologies
  - 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.5.2. Treatment Portfolio
  - 15.3.5.3. Financial Overview
  - 15.3.5.4. SWOT Analysis
  - 15.3.5.5. Strategic Overview
- 15.3.6. Merck KGaA
  - 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.6.2. Treatment Portfolio
  - 15.3.6.3. Financial Overview
  - 15.3.6.4. SWOT Analysis
  - 15.3.6.5. Strategic Overview
- 15.3.7. Aimmune Therapeutics
  - 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.7.2. Treatment Portfolio
  - 15.3.7.3. Financial Overview
  - 15.3.7.4. SWOT Analysis
  - 15.3.7.5. Strategic Overview
- 15.3.8. Carcassia
  - 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.8.2. Treatment Portfolio
  - 15.3.8.3. Financial Overview
  - 15.3.8.4. SWOT Analysis
  - 15.3.8.5. Strategic Overview
- 15.3.9. Anergis
  - 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.9.2. Treatment Portfolio
  - 15.3.9.3. Financial Overview
  - 15.3.9.4. SWOT Analysis
  - 15.3.9.5. Strategic Overview
- 15.3.10. Biomay AG
  - 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.3.10.2. Treatment Portfolio
  - 15.3.10.3. Financial Overview
  - 15.3.10.4. SWOT Analysis
  - 15.3.10.5. Strategic Overview

アレルギー免疫療法市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Allergy Immunotherapy Market [Treatment: Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)]- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

アレルギー免疫療法市場 - レポートの範囲

目次

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：治療法別

第7章世界市場の分析と予測：アレルギータイプ別

第8章世界市場の分析と予測：流通チャネル別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東・アフリカ市場の分析と予測

第15章競合情勢

List of Figures

List of Tables

Allergy Immunotherapy Market - Scope of Report

Key Questions Answered in Global allergy immunotherapy Market Report:

Allergy Immunotherapy Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy Immunotherapy Market

4. Market Overview

5. Key Insights

6. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment

7. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type

8. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel

9. Global Allergy Immunotherapy Market Analysis and Forecast, by Region

10. North America Allergy Immunotherapy Market Analysis and Forecast

11. Europe Allergy Immunotherapy Market Analysis and Forecast

12. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast

13. Latin America Allergy Immunotherapy Market Analysis and Forecast

14. Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast

15. Competition Landscape

アレルギー免疫療法市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年～2031年

Allergy Immunotherapy Market [Treatment: Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)]- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

アレルギー免疫療法市場 - レポートの範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 世界市場の分析と予測：治療法別

第7章 世界市場の分析と予測：アレルギータイプ別

第8章 世界市場の分析と予測：流通チャネル別

第9章 世界市場の分析と予測：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

List of Figures

List of Tables

Allergy Immunotherapy Market - Scope of Report

Key Questions Answered in Global allergy immunotherapy Market Report:

Allergy Immunotherapy Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Allergy Immunotherapy Market

4. Market Overview

5. Key Insights

6. Global Allergy Immunotherapy Market Analysis and Forecast, by Treatment

7. Global Allergy Immunotherapy Market Analysis and Forecast, by Allergy Type

8. Global Allergy Immunotherapy Market Analysis and Forecast, by Distribution Channel

9. Global Allergy Immunotherapy Market Analysis and Forecast, by Region

10. North America Allergy Immunotherapy Market Analysis and Forecast

11. Europe Allergy Immunotherapy Market Analysis and Forecast

12. Asia Pacific Allergy Immunotherapy Market Analysis and Forecast

13. Latin America Allergy Immunotherapy Market Analysis and Forecast

14. Middle East & Africa Allergy Immunotherapy Market Analysis and Forecast

15. Competition Landscape

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：治療法別

第7章世界市場の分析と予測：アレルギータイプ別

第8章世界市場の分析と予測：流通チャネル別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東・アフリカ市場の分析と予測

第15章競合情勢